| |
| |
|
| Insider
Information: |
Perlmutter Roger M |
| Relationship: |
Exe V-P & Pres, MRL |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
413,459 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$78,369,043 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
413,459 |
|
|
| Total
Value |
$78,369,043 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
EVP, Research & Develo... |
2012-02-02 |
186,031 |
2003-07-31 |
0 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2012-12-14 |
13,000 |
2009-12-14 |
0 |
Premium* |
|
|
Merck & Co Inc |
MRK |
Exe V-P & Pres, MRL |
2020-02-28 |
214,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2020-02-28 |
4 |
A |
$76.56 |
$2,683,351 |
D/D |
35,049 |
214,428 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$2,647,476 |
D/D |
32,937 |
175,336 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-11-08 |
4 |
S |
$75.27 |
$16,967,967 |
D/D |
(225,443) |
141,555 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-11-08 |
4 |
OE |
$44.98 |
$10,140,426 |
D/D |
225,443 |
366,998 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2018-02-27 |
4 |
A |
$54.72 |
$1,911,424 |
D/D |
34,931 |
138,907 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2017-02-27 |
4 |
A |
$65.85 |
$2,151,320 |
D/D |
32,670 |
101,601 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,464 |
94,899 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2016-05-06 |
4 |
D |
$54.09 |
$1,457,509 |
D/D |
(26,946) |
67,953 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRL |
• • – |
2016-02-22 |
4 |
A |
$50.77 |
$1,280,775 |
D/D |
25,227 |
50,227 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & Pres, MRLOfficer |
• – – |
2013-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2012-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2012-02-02 |
4 |
OE |
$58.61 |
$4,395,750 |
D/D |
75,000 |
261,031 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2012-02-02 |
4 |
S |
$69.83 |
$5,237,325 |
D/D |
(75,000) |
186,031 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2011-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-04-29 |
4 |
D |
$57.14 |
$77,539 |
D/D |
(1,357) |
186,031 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-04-28 |
4 |
D |
$56.82 |
$77,105 |
D/D |
(1,357) |
187,388 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-04-26 |
4 |
D |
$54.69 |
$74,214 |
D/D |
(1,357) |
188,745 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,800 |
190,102 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Research & Development |
• – – |
2011-03-11 |
4 |
D |
$51.84 |
$423,999 |
D/D |
(8,179) |
174,302 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,520 |
182,481 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2010-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2010-04-29 |
4 |
D |
$58.18 |
$81,510 |
D/D |
(1,401) |
164,961 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2010-04-28 |
4 |
D |
$57.84 |
$81,034 |
D/D |
(1,401) |
166,362 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2010-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
167,763 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Research & Development |
• – – |
2010-03-12 |
4 |
D |
$57.49 |
$330,740 |
D/D |
(5,753) |
155,763 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
